Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Leukemia inhibitory factor increases glucose uptake in mouse skeletal muscle

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  1. A sandwich ELISA for measurement of the primary glucagon-like peptide-1 metabolite

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Direct effect of incretin hormones on glucose and glycerol metabolism and hemodynamics

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Early development of tendinopathy in humans: Sequence of pathological changes in structure and tissue turnover signaling

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Molecular indicators of denervation in aging human skeletal muscle

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Muscle-strain injury exudate favors acute tissue healing and prolonged connective tissue formation in humans

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. An anti-inflammatory phenotype in visceral adipose tissue of old lean mice, augmented by exercise

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  • Nina Brandt
  • Hayley M O'Neill
  • Maximilian Kleinert
  • Peter Schjerling
  • Erik Vernet
  • Gregory R Steinberg
  • Erik A Richter
  • Sebastian B Jørgensen
Vis graf over relationer
Abstract

Members of the IL-6 family, IL-6 and ciliary neurotrophic factor (CNTF), have been shown to increase glucose uptake and fatty acid oxidation in skeletal muscle. However, the metabolic effects of another family member, leukemia inhibitory factor (LIF), are not well characterized. Effects of LIF on skeletal muscle glucose uptake and palmitate oxidation and signaling were investigated in ex vivo incubated mouse soleus and EDL muscles from muscle-specific AMPKα2 kinase-dead, muscle-specific SOCS3 knockout, and lean and high-fat-fed mice. Inhibitors were used to investigate involvement of specific signaling pathways. LIF increased muscle glucose uptake in dose (50-5,000 pM/l) and time-dependent manners with maximal effects at the 30-min time point. LIF increased Akt Ser473 phosphorylation (P) in soleus and EDL, whereas AMPK Thr172 P was unaffected. Incubation with parthenolide abolished LIF-induced glucose uptake and STAT3 Tyr705 P, whereas incubation with LY-294002 and wortmannin suppressed both basal and LIF-induced glucose uptake and Akt Ser473 P, indicating that JAK and PI 3-kinase signaling is required for LIF-stimulated glucose uptake. Incubation with rapamycin and AZD8055 indicated that mammalian target of rapamycin complex (mTORC)2, but not mTORC1, also is required for LIF-stimulated glucose uptake. In contrast to CNTF, LIF stimulation did not alter palmitate oxidation. LIF-stimulated glucose uptake was maintained in EDL from obese insulin-resistant mice, whereas soleus developed LIF resistance. Lack of SOCS3 and AMPKα2 did not affect LIF-stimulated glucose uptake. In conclusion, LIF acutely increased muscle glucose uptake by a mechanism potentially involving the PI 3-kinase/mTORC2/Akt pathway and is not impaired in EDL muscle from obese insulin-resistant mice.
OriginalsprogEngelsk
TidsskriftA J P: Endocrinology and Metabolism (Online)
Vol/bind309
Udgave nummer2
Sider (fra-til)E142-53
ISSN1522-1555
DOI
StatusUdgivet - 15 jul. 2015

ID: 46032409